Company Filing History:
Years Active: 1998
Title: Norio Shiomi: Innovator in Health-Related Inventions
Introduction
Norio Shiomi is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of health-related inventions, particularly focusing on the management of blood glucose levels. His innovative work has implications for the prevention of obesity and diabetes mellitus.
Latest Patents
Norio Shiomi holds a patent for an .alpha.-glucosidase inhibitor, which is a composition principally comprising sugar. This invention relates to an .alpha.-glucosidase inhibitor that mildly inhibits the enzyme locally present in the micro-villus of the small intestine. The composition is designed to delay the digestion of starch, starch-derived oligosaccharides, and sucrose. As a result, it helps suppress the rapid increase in blood glucose levels and insulin secretion at lower levels. This invention is particularly useful for the prophylaxis of obesity and diabetes mellitus. The .alpha.-glucosidase inhibitor is composed of nucleotide, nucleoside, or base as the structural component of nucleic acid, combined with one or more digestible sugars selected from sucrose, starch, and starch-derived oligosaccharides.
Career Highlights
Norio Shiomi is associated with the Hokuren Federation of Agricultural Cooperatives, where he applies his expertise in developing health-related products. His work has been instrumental in advancing the understanding of how certain inhibitors can affect digestion and metabolic processes.
Collaborations
Norio Shiomi has collaborated with notable colleagues, including Masayuki Tsukada and Hiroyuki Takeda. Their combined efforts have contributed to the development of innovative solutions in the field of health and nutrition.
Conclusion
Norio Shiomi's contributions to the field of health-related inventions, particularly through his patent for an .alpha.-glucosidase inhibitor, highlight his commitment to improving public health. His work continues to have a positive impact on the management of blood glucose levels and the prevention of obesity and diabetes mellitus.